retatrutide nonalcoholic fatty liver disease nash trial A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis retatrutide nonalcoholic fatty liver disease

Epics previous research showed obesity rates among US adults climbing from 40% in 2010 to 45% in 2020

"The comment period for the proposed rule closed on June 18, 2024," an FDA spokesperson wrote in an email to NPR

"The FDA's compounding program aims to protect patients from poor quality compounded drugs, while preserving access to lawfully marketed compounded drugs for patients." Experts say people who would like to take the brand names of the medications should check on their insurance coverage every few months because coverage may change

Retatrutide vs Mounjaro also varies in availability because Retatrutide remains in clinical development and Mounjaro already holds prescribing approval for type 2 diabetes